Use access key #2 to skip to page content.
$0.35 0.02 (6.06%)
11/21/2008 3:59 PM

Antares Pharma, Inc. (AIS)

CAPS Rating:
No stars

The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral fast melting tablets and reusable needle-free and disposable mini-needle injector systems.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

Ticker Not Ratable

AIS doesn't currently meet the $100M market cap / $1.50 stock price minimum. (Learn More)

What the Community Thinks

Total Members

12 Outperforms
1 Underperforms
 

All-Stars

3 Outperforms
0 Underperforms
 

Members bullish on AIS are also bullish on:

Members bearish on AIS are also bearish on:

Ticker Tags

Micro Cap (5043), Healthcare Equipment and Supplies (183)
Suggest a tag

Antares Pharma, Inc. At A Glance

Current Price: $0.35
Last Trade Time: 11/21/2008 3:59 PM
Open: $0.34
Previous Close: $0.33
Daily Range: $0.33 - $0.38
52-Week Range: $0.31 - $1.20
Volume: 209,805
Market Cap: $22.43M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

AIS VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for AIS

More Headlines...

Top Bull Pitch

Recs

1

Antares Pharma, Inc. (AIS)

Avatar joemaller (< 20) Submitted: 6/01/07 10:57 AM

Been waiting for this one to cap $100M. Posted profits last quarter and showing trends that they can actually make money from their products in the marketplace. In development are other new transdermal and gel-based delivery platforms, including insulin for diabetes. Up 50% already this year.

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 2 of 2  

Recs

0

 (AIS)

Avatar AtomicDoom (78.67) Submitted: 7/01/07 4:26 PM : Underperform Start Price: $1.58 AIS Score: 28.11

Call my old-school, but when fundamentals suck (ie company's still in the red, despite revenue growth) there's still room to go down at $1.58.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (AIS)

Avatar joemaller (< 20) Submitted: 6/01/07 10:57 AM : Outperform Start Price: $1.92 AIS Score: -31.08

Been waiting for this one to cap $100M. Posted profits last quarter and showing trends that they can actually make money from their products in the marketplace. In development are other new transdermal and gel-based delivery platforms, including insulin for diabetes. Up 50% already this year.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 2 of 2  

Wall Street

There are no Wall Street tracker picks.

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

Sponsored Links